NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $414,000 | -62.0% | 29,577 | -51.3% | 0.00% | -66.7% |
| Q3 2021 | $1,090,000 | +4.7% | 60,759 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,041,000 | +231.5% | 60,759 | +252.3% | 0.01% | +100.0% |
| Q3 2019 | $314,000 | -72.3% | 17,247 | -45.8% | 0.00% | -70.0% |
| Q2 2019 | $1,134,000 | +19.1% | 31,847 | +12.5% | 0.01% | +11.1% |
| Q1 2019 | $952,000 | -10.4% | 28,297 | -12.5% | 0.01% | -10.0% |
| Q4 2018 | $1,063,000 | -20.1% | 32,343 | +48.2% | 0.01% | 0.0% |
| Q3 2018 | $1,330,000 | +13.3% | 21,820 | -9.2% | 0.01% | 0.0% |
| Q2 2018 | $1,174,000 | -23.8% | 24,020 | +65.7% | 0.01% | -33.3% |
| Q1 2018 | $1,541,000 | – | 14,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |